Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer. [electronic resource]
Producer: 20160810Description: 13-23; discussion 23-4 p. digitalISSN:- 1873-4626
- Animals
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- DNA Damage -- drug effects
- DNA Repair -- drug effects
- Diterpenes -- pharmacology
- Down-Regulation -- drug effects
- Epoxy Compounds -- pharmacology
- Female
- Humans
- Mice
- Organophosphates -- pharmacology
- Organoplatinum Compounds -- pharmacology
- Oxaliplatin
- Pancreatic Neoplasms -- drug therapy
- Phenanthrenes -- pharmacology
- Random Allocation
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.